1. Home
  2. NEUE vs VRCA Comparison

NEUE vs VRCA Comparison

Compare NEUE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • VRCA
  • Stock Information
  • Founded
  • NEUE 2015
  • VRCA 2013
  • Country
  • NEUE United States
  • VRCA United States
  • Employees
  • NEUE N/A
  • VRCA N/A
  • Industry
  • NEUE
  • VRCA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEUE
  • VRCA Health Care
  • Exchange
  • NEUE NYSE
  • VRCA Nasdaq
  • Market Cap
  • NEUE 60.7M
  • VRCA 58.0M
  • IPO Year
  • NEUE 2021
  • VRCA 2018
  • Fundamental
  • Price
  • NEUE $6.85
  • VRCA $0.43
  • Analyst Decision
  • NEUE Hold
  • VRCA Hold
  • Analyst Count
  • NEUE 1
  • VRCA 5
  • Target Price
  • NEUE $7.00
  • VRCA $6.00
  • AVG Volume (30 Days)
  • NEUE 44.8K
  • VRCA 532.2K
  • Earning Date
  • NEUE 03-20-2025
  • VRCA 03-11-2025
  • Dividend Yield
  • NEUE N/A
  • VRCA N/A
  • EPS Growth
  • NEUE N/A
  • VRCA N/A
  • EPS
  • NEUE N/A
  • VRCA N/A
  • Revenue
  • NEUE $936,657,000.00
  • VRCA $7,566,000.00
  • Revenue This Year
  • NEUE $13.81
  • VRCA $93.38
  • Revenue Next Year
  • NEUE $6.75
  • VRCA $127.27
  • P/E Ratio
  • NEUE N/A
  • VRCA N/A
  • Revenue Growth
  • NEUE N/A
  • VRCA 47.66
  • 52 Week Low
  • NEUE $3.79
  • VRCA $0.42
  • 52 Week High
  • NEUE $7.66
  • VRCA $11.41
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 55.68
  • VRCA 29.54
  • Support Level
  • NEUE $4.30
  • VRCA $0.42
  • Resistance Level
  • NEUE $6.99
  • VRCA $0.66
  • Average True Range (ATR)
  • NEUE 0.64
  • VRCA 0.08
  • MACD
  • NEUE 0.15
  • VRCA -0.02
  • Stochastic Oscillator
  • NEUE 92.73
  • VRCA 5.26

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: